Dr. Selwyn is a Scientific Advisory Board Member of FluoroPharma.
He is Professor of Medicine at Harvard Medical School and a Senior Physician and Associate Chief of the Cardiovascular Division (academic affairs) at Brigham and Women’s Hospital. He is a leading contributor to the research and clinical practice of interventional cardiology and biology of atherosclerosis.
Dr. Selwyn conducted his postdoctoral training at the Royal Postgraduate Medical School in London. He received his MD degree from University of Cape Town, South Africa.